Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 1 2Phase 3 1

Status

Terminated 8Withdrawn 1Completed 1

Sponsor Class

INDUSTRY 8

Study Type

Interventional 8

Sponsor

Cancer Type

Thoracic 4Tumor-Agnostic 2Gastrointestinal 2Breast 1

Conditions

Non-small Cell Lung Cancer Metastatic 2Neoplasms 2Non-squamous Non-small-cell Lung Cancer (NSQ NSCLC) 1Non-squamous Non-small Cell Lung Cancer 1Breast Cancer Metastatic 1Adenocarcinoma Gastric 1

Interventions

Cyclophosphamide 391Carboplatin 344Gemcitabine 332pembrolizumab 331Cisplatin 328Paclitaxel 298Radiotherapy 297Docetaxel 287Bevacizumab 253Rituximab 234Capecitabine 224Nivolumab 222Dexamethasone 206Fluorouracil 190fludarabine 178Oxaliplatin 177Pemetrexed 153Doxorubicin 153Irinotecan 148Leucovorin 144Etoposide 144Cytarabine 134Cetuximab 130fludarabine phosphate 129Bortezomib 129Lenalidomide 126Filgrastim 120Erlotinib Hydrochloride 120Temozolomide 113Radiosurgery 113

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

8 trials
RecentStart dateEnrollment
Terminated × tusamitamab ravtansine × Clear all
NCT04154956 2026-05-18

CARMEN-LC03

Sanofi

Phase 3 Terminated
389 enrolled 16 charts
Thoracic

Non-small Cell Lung Cancer Metastatic

NCT04524689 2025-10-29

CARMEN-LC05

Sanofi

Phase 2 Terminated
57 enrolled 26 charts
Thoracic

Non-squamous Non-small-cell Lung Cancer (NSQ NSCLC)

NCT04659603 2025-10-01

CARMEN-BT01

Sanofi

Phase 2 Terminated
50 enrolled 20 charts
BreastGastrointestinal

Breast Cancer Metastatic

NCT05245071 2025-08-29

CARMEN-LC06

Sanofi

Phase 2 Terminated
22 enrolled 11 charts
Thoracic

Non-squamous Non-small Cell Lung Cancer

NCT05071053 2025-08-22

CARMEN-GC01

Sanofi

Phase 2 Terminated
35 enrolled 14 charts
Gastrointestinal

Adenocarcinoma Gastric

NCT04394624 2025-06-06

CARMEN-LC04

Sanofi

Phase 2 Terminated
31 enrolled 22 charts
Thoracic

Non-small Cell Lung Cancer Metastatic

NCT05429762 2025-04-06

TusaRav-QT

Sanofi

Phase 1 Terminated
56 enrolled
Tumor-Agnostic

Neoplasms

NCT02187848 2025-02-10

Evaluation of SAR408701 in Patients With Advanced Solid Tumors

Sanofi

Phase 1 Terminated
254 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡